Information

44: Biochemical Test Table - Biology

44: Biochemical Test Table - Biology


We are searching data for your request:

Forums and discussions:
Manuals and reference books:
Data from registers:
Wait the end of the search in all databases.
Upon completion, a link will appear to access the found materials.

44: Biochemical Test Table

Biochemical Test and Identification of Proteus mirabilis

What are the biochemical test and identification of Proteus vulgaris?

first and foremost the most identifications of test for proteus spp by urease test ,PPA
The socond biochemical test indole the are defrenciate to p. Mirabilis from p vulgaris. If indole positve_ P.vllulgaris if negative – P.mirabilis

may I know the result for coagulase test?

What is best identification of corynebacterium diphtheria

Loefler’s serum slant or Tindales agar are selective media for cornye. Cornye has a particular look on the Tinsdale agar. Then you’ll do your regular gram stains (Gram Positive bacilli, sometimes with club shape), catalase (positive), urease test (negative), growth is not supported on a MacConkey agar. Albert stain for confirmation to show green tail and reddish metachromatic granules. Carbohydrate Fermentation test: Maltose- Negative , Dextrose-Positive, Starch-Positive, Sucrose-Negative. The positive results for the starch and the negative results for the sucrose show the presence of a species of Corynebacterium diphtheriae (gravis).

what is media choice of growing Proteus mirabilis

Nutrient agar is always a safe choice. MacConkey is usually fairly decent, especially if you want to test the lactose fermentation thing. Finally, blood agar is always really cool for p. mirabilis, because the organism has a tendency to swarm across the agar (because of it’s high motility), so that’s cool to see.


Microboids

Sharing Knowledge improves Knowledge. Knowledge should come at as less cost as possible.

  • Get link
  • Facebook
  • Twitter
  • Pinterest
  • Email
  • Other Apps

Lab series# 15: Biochemical tests for identification of bacterial isolates

In earlier days, most tests were done in large volumes typically using more than 5ml of a medium which takes more time to produce a visible result. Let us take an example case of lactose utilisation. If I’m to put an E coli into 5ml of a lactose-containing medium, it would take the isolate more time to break down lactose and give a pH change sufficient enough to give a reading in comparison to doing the same in a 0.1 ml medium. The simplest way to minimise the time involved in reading it to reduce the total reaction volume, which is one of the key concept in the most automated system allowing faster reading of results. Fig 1, is a hypothetical graph showing the time required to give a positive result in different conditions (The exact details will change depending on the test and other conditions).

Table 1: Hemolysis patterns that are
seen in blood agar.
In a typical scenario, Hemolysis is not considered as a biochemical test and many microbiologists would resist calling it so. For most of the cases, hemolysis pattern in blood agar significantly narrows down the identification. There are 4 types of hemolysis pattern that can be seen in a blood agar.

It should be noted that hemolysis is dependent on the enzyme involved and variations are seen for the same species depending on conditions. A study by Vancanneyt et al which tested multiple strains of E faecium found the following. beta-hemolysis was observed on both sheep and human blood for only 1 strain, 4 strains showed beta-hemolysis on human blood, but not on sheep blood, and rest of the strains studied showed no hemolysis on either medium. Of course, beta hemolysis is not a common feature for Enterococcus group.

Photo 1: Blood agar Plate. Source
For the preparation of Blood agar, sheep blood is the recommended reagent. Most commonly, the obtained sheep blood is defibrinated (using sterile glass beads) and added onto the basal medium to get blood agar. In my experience, washing the blood sample with normal saline and subsequent use of washed sheep RBC gives slightly better results. Certain labs also use horse/ bovine blood without significant deviations in the result.
Fig 1: SOD and Catalase activity.
From Prescott Textbook 5th Ed
I want to digress a little bit since it would be useful. In general, obligate aerobes and facultative anaerobes usually contain the enzymes superoxide dismutase (SOD) and catalase, which catalyse the destruction of superoxide radicals and hydrogen peroxide, respectively. Most strict anaerobes lack both enzymes or have them in very low concentrations and therefore cannot tolerate O 2 There are multiple exceptions to these rules. Peroxidases also can be used to destroy hydrogen peroxide. Fig 2 is an illustration of the growth of bacteria with varying responses to oxygen and their catalase and SOD properties.
  • Qualitative catalase
  • SQ (Semi Quantitative) catalase test
  • 68 C (Heat stable) catalase test
Photo 2: Catalase test. Source
The reagent used for qualitative catalase testing is 3% Hydrogen peroxide, though up to 6% is acceptable. The test can be done by mixing a colony with a few drops of H 2 O 2 in a slide (Slide method), adding a small colony to test tube containing H 2 O 2 (Tube method) or adding H 2 O 2 to the culture plate/ slant directly (Direct method) and looking for the formation of bubbles within 10sec. Care should be taken that the culture medium from which colony is used is devoid of RBCs and inert materials (such as plastic applicator stick, nichrome wire etc) should be used for mixing the colonies with the reagent.
Photo 3: Oxidase Test. Source
The test identifies the presence of cytochrome c oxidase or indophenol oxidase. The test is based on the principle of Redox (Reduction-oxidation) reaction. Redox reactions are in simple terms, a set of reactions that involve the transfer of electrons. It is a bi-component reaction, involving oxidation which is a loss of electrons and, a reduction which is a gain of electrons. The oxidase test often uses a reagent, tetra-methyl-p-phenylenediamine dihydrochloride, as an artificial electron donor. When the reagent is oxidised it changes from colourless to a dark blue or purple compound, indophenol blue.

Classically, 1% tetra-methyl-p-phenylenediamine dihydrochloride is freshly prepared daily and impregnated into a filter paper and dried. The colonies are smeared on the paper and look for colour change within 10 sec. Commercially available discs are now available which contains N, N-dimethyl-p-phenylenediamine oxalate, ascorbic acid and α-naphthol, a combination which is more stable thus avoiding the requirement of daily preparation.

Modified oxidase test is a special test used only for Gram positive, catalase positive cocci. It is commonly referred as Microdase test. Micrococcus oxidase enzyme is not readily accessible for reaction. This problem is overcome by the use of DMSO which permeabilizes the cell and permits access of reagents to oxidase enzyme.


Uses of Urease Test

  1. This test is used to differentiate organisms based on their ability to hydrolyze urea with the enzyme urease.
  2. This test can be used as part of the identification of several genera and species of Enterobacteriaceae, including Proteus, Klebsiella, and some Yersinia and Citrobacter species, as well as some Corynebacterium species.
  3. It is also useful to identify Cryptococcus spp., Brucella, Helicobacter pylori, and many other bacteria that produce the urease enzyme.
  4. Directly, this test is performed on gastric biopsy samples to detect the presence of H. pylori.

Impacts of methamidophos on the biochemical, catabolic, and genetic characteristics of soil microbial communities

Methamidophos is an organophosphate pesticide with high toxicity and may significantly affect soil microbes. However, the magnitude of this effect is unclear. We examined the effect of low and high inputs of methamidophos on the structure of the soil microbial community, and the catabolic activity and the genetic diversity of the bacterial community using the polyphasic approaches of microbial biomass, phospholipid fatty acids (PLFAs), community-level catabolic profiles (CLCPs), and amplified ribosomal DNA restriction analysis (ARDRA) patterns. Our results indicated that high methamidophos inputs significantly reduced total microbial biomass carbon (Cmic) and fungal biomass, but increased Gram-negative bacteria with no significant effects on the Gram-positive bacteria. Interestingly, CLCPs patterns showed that high methamidophos inputs also significantly improved the catabolic activity of Gram-negative bacteria. The ARDRA pattern showed that the genetic diversity of the bacterial community decreased under chemical stress. Furthermore, changes in the microbial parameters examined were less significant under low inputs than high inputs of methamidophos, suggesting a dosage effect of methamidophos on the microbial community. Our results provide the first evidence that methamidophos differentially affected components of the soil microbial community through inhibiting fungal growth but enhancing the biomass and catabolic activity of Gram-negative bacteria.


Sucrose Hydolysis by Sucrase

In this lab, you will demonstrate the production of the enzyme sucrase (invertase) by yeast. The enzyme sucrase catalyzes the hydrolysis of the disaccharide sucrose to invert sugar. Invert sugar is a mixture of glucose and fructose, which are both monosaccharides. Yeast cannot directly metabolize (ferment) sucrose. For the yeast to utilize sucrose as an energy source, it must first convert it to the fermentable monosaccharides glucose and fructose.
Benedict’s solution is a test reagent that reacts positively with simple reducing sugars. All monosaccharides and most disaccharides are reducing sugars, possessing a free carbonyl group (=C=O). Sucrose is an exception in that it is not a reducing sugar. A positive Benedict’s test is observed as the formation of a brownish-red cuprous oxide precipitate. A weaker positive test will be yellow to orange. Both glucose and fructose test positive with benedict’s solution, sucrose does not.

*Yeast filtrate solution
one 7 gram package active dry yeast per 80 mL distilled water
Ring stand and ring to hold funnel
Filtering funnel
Filter paper (fast speed)
**5% sucrose solution
5 grams sucrose per 95 mL distilled water
***5% glucose (dextrose) solution
5 grams dextrose per 95 mL distilled water
Benedict’s qualitative solution
Distilled water
Five 10-mL graduated cylinders (one for each solution)
7 test tubes 18 x 150 mm
Test tube holder
Test tube rack
2 400-mL beakers
Hot plate

* To prepare a yeast filtrate solution, mix one package of active dry yeast with 80 mL of distilled water. Let stand for 20 minutes, stirring occasionally. Filter the resulting suspension and save the filtrate solution. This is your invertase extract. Refrigerate the extract if held overnight. Approximately enough for 8 labs.

**To prepare a 5% sucrose solution, dissolve 5 grams of sucrose in 95 mL of distilled water. This should be prepared shortly before use. Approximately enough for 4 labs.

***To prepare a 5% glucose solution, dissolve 5 grams of dextrose (this is the name used when dry) in 95 mL of distilled water. This should be prepared shortly before use. Approximately enough for 9 labs.

1. Label 3 test tubes A1, A2, and A3, and place in the test tube rack. Place into the test tubes as follows:

Into tube A2, place 10 mL of 5% sucrose solution and 4 mL of invertase extract.

Into tube A3, place 10 mL distilled water and 4 mL of invertase extract.

2. Put approximately 250 mL of 30 to 35 oC water into a 400-mL beaker. Incubate the three tubes in this warm water bath for 35 minutes.

3. Label 4 test tubes B1, B2, B3 and B4, and place in the test tube rack. Place 5 mL of Benedict’s qualitative solution into each tube. Now transfer to the B tubes as follows:

Into tube B2, transfer the contents of tube A2.

Into tube B3, transfer the contents of tube A3.

Into tube B4, place 10 mL of 5% glucose solution.

4. Place tubes B1, B2, B3, and B4 into a boiling water bath. CAUTION: do not let the bath boil hard. Keep it just at the boiling point. After 3 or 4 minutes, remove the tubes and note whither any change is evident.


Identification of Bacterial Growth: 3 Mediums

1. Observe and record the morphology of colony and pigment production in nutrient agar plate or tube. To identify a bacteria by its colonial morpho­logy only, may not be enough. So a battery of other relevant tests is to be undertaken.

However, pigment production, if present, may give some clue. Generally, bacterial growth with green pigment on nutrient agar is supplied. Pigment is diffusible in the medium in case of pigmented Pseudomonas (Fig. 7.2) whereas Staphylococcal pig­ment remains localised within the bacterial colony (Fig. 7.1), e.g. golden-yellow pigment in Staph, aureus and white pigment in Staph, epidermidis.

In liquid medium like peptone water, greenish pigment may also be present with surface pellicle formation. Surface pellicle (e.g. in cases of vibrio and Bacillus) indicates strong aerobic nature of bacteria as more oxygen is available near surface.

2. Examine Gram’s stained smear and hanging drop preparation.

(b)Gram-positive cocci in clusters (Staphylococci)

(c) Gram-positive rods with or without spore

The findings are recorded and Tables 7.3, B, C, G & H are followed to arrive at identity.

Growth on Any Other Special (Selective/Inhibitory/Indicator) Medium:

Any growth on special selective/indicator/ inhibitory medium is to be identified by undertaking the following steps:

1. Identify the medium and think the bacteria which grows on it.

2. Note the colony character and any indicator of growth for any special genus, e.g., sucrose fermenting flat yellow colony on T.C.B.S. agar indicates growth of vibrio.

3. Perform morphological study by gram stain or any special stain (eg. capsule staining, spore staining, Wayson’s staining for Y. pestis etc.).

6. Go for biochemical tests.

7. Tests for enzyme and toxin production.

8. Antigen detection by slide agglutination or capsule swelling using specific high titre sera (HTS).

A. Pseudomonas Aeruginosa:

The organisms produce blue pus and pyocyanea literally means “blue pus”. Ps. aeruginosa is an impo­rtant cause of hospital-acquired infection. Most infections occur in patients with serious underlying diseases like burns and malignancy or as a result of therapeutic procedures (catheterisation, cystoscopy). Prior treatment with antimicrobials favour pseudo­monas infection.

1. Skin infections especially in wound, pressure sores and burns.

2. Urinary infection, usually following catheteri­sation or in chronic infections.

3. Respiratory infections, especially in immuno­suppression and cystic fibrosis.

4. Ear infections, e.g. chronic otitis media and otitis externa.

5. Eye infections, usually hospital acquired.

6. Septicaemia may develop in neonates and old debilitated persons, particularly in patients receiving cytotoxic drug or irradiation.

7. Acute necrotising vasculitis which leads to haemorrhagic infarction of skin (ecthymagangrenosa) and of internal organs (liver and kidney).

Laboratory diagnosis:

Pus, wound swab, mid-stream speci­men of urine, CSF, sputum or blood.

On MacConkey’s agar they show pale, flat colonies with a spreading border. In nutrient agar or Mueller-Hinton agar there is diffuse bluish, greenish or reddish brown pigments, and a grape­like or fruit-like odour. Selective media such as cetrimide agar is useful for isolation of the organism from faeces or other samples contaminated with mixed flora.

Identification is made based on:

1. Characteristic colony morphology and gram- film appearance.

2. Grape-like or fruit-like odour of the colony.

3. Mucoid colony variants are particularly pre­valent in respiratory tract specimens.

4. Biochemically, P. aeruginosa is confidently identified based on the following features:

(a) Positive oxidase test (Table 7.10).

(b) Triple sugar iron (TSI) agar reaction of alkaline over no change.

(c) Bright green diffusible pigments on Mueller-Hinton or other non-dye-containing agars (e.g. N. agar).

Occasional strains of P. aeruginosa produce only pyoverdin, which would not differentiate them from P. fluorescens or P. putida. These latter species fail to grow at 42°C, while P. aeruginosa grows at 42°C.

B. Staphylococcus (S.aureus):

S. aureus is an important pyogenic organism and Box 1 shows the important diseases produced by the same.

Laboratory diagnosis:

These are to be collected depending on the nature of lesion, pus from suppurative lesions, CSF from meningitis, blood from septicaemia, sputum from respiratory infection and suspected food, vomit or faeces from food poisoning.

Examination of a Gram-stained smear of pus and other specimens shows Gram-positive cocci in clusters with some single and paired cocci.

(a) Specimens are inoculated on blood agar or selective agar medium with 7% sodium chloride which inhibits the growth of most organi­sms other than staphylococci.

(b) Mannitol salt agar is selective and differential media for staphylococci. Mannitol is fermented by S. aureus but not most other staphylococci.

(a) Coagulase test: S. aureus is coagulase positive.

(b) Antibiotic susceptibility tests, biochemical profiles (bio-typing), phage typing, nucleic acid analysis may be done for the intra-species identifica­tion of the organism for epidemiological study to trace the source of staphylococcal infections.

C. Bacillus:

Members of the genus Bacillus are aerobic, spore- bearing, gram-positive bacilli arranged in chain. The spores are retractile, oval and central in position and its diameter is the same as the width of the bacteria.

Bacillus anthracis:

(a) B. anthracis — causative agent of anthrax.

(b) B. cereus — cause food poisoning.

II. Non-pathogenic (saprophytes):

(1) Large-celled: B. megaterium, B. cereus

(2) Small-celled: B. subtilis, B. stearothermophilus

Anthrax is a zoonosis, humans are occasionally secondarily infected from diseased animal or animal products.

Anthrax is of 4 clinical types:

Spores enter the skin most commonly through abraded skin, crusts or hair follicles and usually produce a single painless blister, often called ‘malignant pustule’.

Ingestion of contaminated meat results in severe and often fatal form of gastroenteritis which is far less common than cutaneous form.

It is often referred to as ‘wool-sorter’s disease’ and is caused by inhalation of large number of spores and is usually fatal. It is a rare form of anthrax in developing countries.

(4) Septicaemia anthrax:

Cutaneous intestinal and pulmonary anthrax, if not treated in time, progress into septicaemia and death occurs from overwhelming infection.

Specimens: Pus, fluid, sputum or blood depend­ing on the type of lesion. Specimen must be labelled “High Risk”.

B. anthracis is capsulated, non-motile, large (5-8/1.5 μm), gram-positive rod with square ends. Spore forms never occur in tissues but develop after the organism is shed or if it is grown on artifi­cial media. Spores can be stained by modified Ziehl- Neelsen’s method. Capsules are formed in the tissues but are usually lacking in culture.

When B. anthracis in blood of animals in a heat fixed film is stained with polychrome methylene blue for 10-20 seconds, disintegrated capsular material appears amorphous and purplish around the bacilli.

B. anthracis is aerobe and facultative anaerobe, grows readily on ordinary media over a wide-range of temperature (25°-30°C), optimum 35°C. Colonies are 2-5 mm in diameter, dense, grey-white they are composed of parallel chains of cells producing wavy margin of the colony, the so-called ‘Medusa head’ or ‘curled hair lock’ appearance.

Colonies are non-haemolytic or only slightly haemolytic (saprophytic Bacilli species are markedly haemolytic).

Growth is not usually turbid but forms a thick pellicle on the surface.

3. Gelatin stab culture:

Growth occurs along the tract of inoculating wire with lateral spikes, widest near the surface — the “inverted fir tree” appear­ance, but the liquefaction is late.

When white mouse or guinea pig is intra-peritoneally inoculated with a small amount of exudate or, culture, the animal dies in 36-48 hours. Heart blood and sputum shows B. anthracis.

Bacillus subtilis:

It is a non-pathogenic saprophyte and appear as common contaminant of specimen and laboratory media.

Nutrient agar shows dry, 2-3 mm grey­ish-white opaque colonies. In nutrient broth, there is uniform turbidity.

Gram-positive bacilli with sub-terminal spore.

Non-pathogenic to labo­ratory animals. They also differ from B. anthracis in producing β-lactamase which is different from that produced by staphylococci and are motile.

Medium # 2. Blood Agar:

A. Streptococcus:

Streptococcus is a gram-positive coccus arranged in chain.

A. Haemolytic classification:

Preliminary classi­fication of streptococci is made based on the type of haemolysis produced on blood agar plates.

(i) β-haemolytic streptococci:

They produce a wide (2-4 mm wide) clear zone of complete haemolysis around the colony (Fig. 7.8).

(ii) α-haemolytic streptococci:

They produce a partial haemolysis (1-2 mm wide) with greenish discolouration. Some un-haemolysed RBCs are detectable in the haemolytic zone. Alpha haemolysis is seen in pneumococcus and viridans streptococci.

(iii) γ-haemolytic streptococci:

They produce no haemolysis and Streptococcus faecalis is a typical member.

B. Serological classification (Lancefield and Griffith classification):

The β-haemolytic strepto­cocci are classified by Lancefield (1933) serologically into a number of broad groups on the basis of group specific polysaccharide antigen of cell wall. To date, 20 Lancefield groups have been identified, numbered A-V (without I and J) by precipitation reaction with appropriate sera. Majority of the human pathogens belong to group A which are also called Streptococcus pyogenes.

The strains of group A streptococci are further subdivided by type specific antisera into 80 Griffith serotypes (type 1, type 2, etc.) according to their surface proteins (M, T and R). M protein is most important type specific antigen which exists in approximately 80 antigenic forms, each of which is present in a different serotype of S. pyogenes.

Streptococcus pyogenes:

Box 2 shows the important lesions produced by different species of streptococci.

Laboratory diagnosis:

A. Acute suppurative infections:

Specimen is collected from the site of lesion such as swab, pus or blood depending on the nature of infection, such as swabs taken from throat, vagina or purulent lesion of patients and from the throat and nose of suspected carriers.

Microscopy of smears of pus showing Gram-positive spherical or oval cocci in chains or pairs in association with pus cells suggests the presence of streptococci (Fig. 7.7). Non-viable organisms are gram-variable.

Specimen should be inoculated immediately or sent to the laboratory in Pike’s transport medium (blood agar containing 1 in 1,000,000 crystal violet and 1 in 16,000 sodium azide). Specimen is inoculated in blood agar medium and incubated at 37°C overnight. Haemolysis develops better under anaerobic conditions or under 5-10% carbon dioxide.

Sheep blood agar is preferable as human blood may contain inhibitors. The bacterial colonies are small, typically matt or dry and surrounded by β-haemolysis. Haemophilus haemolyticus produces colonies resembling those of β-haemolytic streptococci but their haemolysis is inhibited by sheep blood. Hence primary isolation should be done in sheep blood agar.

Serological testing for determination of Lance- field group and Griffith type of haemolytic streptococci is done when needed for definite classification and for epidemiological study.

A simple technique of detection of S. pyogenes (group A) is done by agar plate test using paper discs impregnated with bacitracin. S. pyogenes is more sensitive to bacitracin than other streptococci. Selective media like crystal violet blood agar that inhibits throat commensals and may facilitate the detection of small numbers of S. pyogenes in throat swabs, but are rarely used in routine culture.

3. Antigen detection tests:

Commercial test kits of ELISA, and agglutination tests are now available to demonstrate group A streptococcal antigen from throat swabs which are 75-80% sensitive.

Commercial test kit of a nucleic acid probe-based test for direct detection of group A streptococci in throat swabs is available.

Although antibodies to most toxins and enzymes of group A streptococci are produced, these antibodies appear late, hence test for antibodies is not helpful in diagnosing acute infection. They are more commonly used to diagnose non-suppurative complications.

B. Non-suppurative complication:

Culture of throat swab or pus from skin lesions helpful for checking the continuing presence of S. pyogenes in throat or impetigo. Serological tests provide evidence of recent streptococcal infection. A rising titre of antibodies to group A streptococcal antigens are usually detectable. ASO titre of 200 units or more is significant in rheumatic fever.

ASO titre is usually found in high levels in respiratory disease and rheumatic fever but in streptococcal skin infections and acute glomerulonephritis, ASO titre tends to be low and DNase-B test is more reliable. Complement (C3) level is also reduced in serum in acute post-streptococcal glomerulone­phritis.

B. Proteus, Morganella, Providencia:

Human and animal intestine. Some species are saprophytes and are found in soil, sewage and water.

P. mirabilis is the most important, other species are occasionally encountered in human lesions.

1. Urinary tract infection, especially following catheterization or cystoscopy.

2. Sepsis: Abdominal, wound and middle ear infections. The organisms are generally low grade pathogens and often are secondary invader of ulcers, pressure sores, burns and damaged tissues.

Laboratory diagnosis:

Depending on the site of infection, which include urine, pus, blood.

These are actively motile, non-capsulate, gram- negative pleomorphic bacilli.

Proteus species grow well on routine media (nutrient agar, blood agar) with a swarming type of growth. This makes the isolation of other bacteria difficult in mixed cultures because swarming from a single colony of Proteus may cover the whole plate culture.

However, swarming is inhibited in media containing bile salts, sewage. MacConkey agar, DCA and XLD agar. Swarming is also inhibited by increasing agar concentration (2%), chloral hydrate (1:500) and boric acid (1:1000) by incorporating in the media.

Colourless, non-lactose fermenting on Mac­Conkey agar. Proteus cultures have a distinctive smell (fishy/seminal).

In a mixed culture, pathogen can be separated from Proteus contaminated plate by sub-culturing in MacConkey agar. Swarming is not exhibited by the Morganella and Providencia.

Table 7.9 shows the distinctive biochemical cha­racters of the three genera.

1. Lactose is not fermented by any of the three genera, hence colonies are pale on MacConkey or DCA.

2. All produce indole except P. mirabilis, and only two members (P. mirabilis and P. vulgaris) produce H2S.

3. All members produce phenylalanine deaminase and deaminate phenylalanine to phenyl pyruvic acid (PPA).

4. Production of urease and hydrolysis of urea is another characteristic of all members of the group except P. stuartii which is urease-negative.

Differentiation from the common pale colonies of pathogens isolated on lactose containing media is made by testing urease activity. Shigella and Salmonella do not produce urease.

Certain antigens (alkali-stable fraction O) of Proteus strains (0 x 19, 0 x K and 0 x 2) are common to Rickettsial prowazekii and agglutinate with sera from patients with rickettsial disease. This antigen sharing forms the basis of Weil-Felix reaction (heterophile agglutination test).

Citrobacter, Enterobacter, Serratia:

Citrobacter, Enterobacter and Serratia species are Gram-negative motile rods and opportunistic patho­gens.

They are found in intestinal tract of man and animal, and in soil, sewage and water.

These members grow well on routine media such as MacConkey agar, blood agar and nutrient agar.

Citrobacters are late or non- lactose fermenters and enterobacters are lactose fermenters. Serratia is a non-lactose fermenting organism. Some strains of Serratia produce red pigment.

Medically important species include C. freundii, E. aerogenes, E. cloacae and S. marcescens.

1. Urinary tract infection.

2. Wounds, skin lesions and respiratory infections in hospitalized patients.

3. Septicaemia: Some are responsible for out­breaks of infection in nursery, ICU and burns units. They are often multi-drug resistant.

Medium # 3. MacConKey’s Agar:

I. Lactose Fermenters:

a.Enterobacteriaceae:

The classification of Enterobacteriaceae is complex and controversial. There has been successive changes in the nomenclature of taxonomy with DNA homology studies. More than 30 genera and 120 species or groups have been defined, about 96% of the medically important isolates belong to 14 genera and constitute 38 species.

The oldest method of classification of enteric bacilli is based on lactose fermentation and members fermenting lactose are called lactose fermenters or coliforms.

b. Escherichia Coli:

The main species of medical importance is Esche­richia coli which are gram-negative motile bacilli.

E. coli is a normal inhabitant of intestinal tract of humans and animals.

UTI, wound infection, peritonitis, biliary tract infection, septicaemia, neonatal meningitis.

Infant gastroenteritis (EPEC), travellers’ diarrhoea (ETEC), haemorrhagic dia­rrhoea (VTEC) (haemorrhagic colitis, haemolytic uraemic syndrome).

E. coli is an important cause of sepsis:

(a) Urinary tract infection including cystitis, pyelitis and pyelonephritis.

(b) Wound infections, appendicitis, peritonitis, biliary tract infection.

II. Diarrhoea:

Despite being a normal gut flora, four pathogenic groups of E. coli are recognised that cause diarrhoea.

(a) Enterotoxigenic E. coli (ETEC):

E. coli produces either one or two plasmid mediated enterotoxins, heat-labile enterotoxin (LT) and heat-stable enterotoxin (ST).

LT stimulate adenyl cyclase in mucosal cells of small intestine, which, in turn, activates cyclic adenosine monophosphate (cAMP) that causes hyper secretion of fluid and electrolytes into the intestinal lumen and produces watery diarrhoea. In contrast, ST appears to activate guanylate cyclase and cause diarrhoea.

(b) Enteroinvasive E. coli (EIEC):

The EIEC are far less pathogenic than ETEC and invade the mucosa of colon and cause a dysentery like shigella dysentery in all age groups. They are non-motile and resemble shigella strains in their biochemical reaction (NLF). Important serogroups are O 124 and O 164.

(c) Enteropathogenic E. coli (EPEC):

EPEC is an important cause of outbreak of infantile gastro­enteritis in developed countries.

(d) Verocytotoxigenic E. coli (VTEC):

VTEC are named so because of the cytopathic effect of their toxins on vero-monkey kidney cells. There are two antigenically distinct verocytotoxins — VT-1 and VT-2. Commonest VTEC is a serogroup O 157 that causes haemorrhagic colitis and haemolytic uraemic syndrome in children.

Laboratory diagnosis:

Depending on the site of infection specimens are collected which include urine, pus, blood and stool. In case of diarrhoeal diseases, faeces may be examined for toxin detection.

E. coli is a gram-negative motile rod. A few strains are non-motile (formerly referred to as Alkalescens dispar group). Some E. coli strains are capsulated.

Specimen is inoculated on MacConkey agar and blood agar plates and incubated at 37°C for over­night.

The colonies are 1-4 mm in diameter, pink, circular, convex, smooth and usually non- viscous in MacConkey agar (Fig. 7.8).

Colonies may be haemolytic.

Growth on other media:

Most strains do not grow or markedly inhibited in xylose-lysine-deoxycholate (XLD), DCA and SS agar.

IMViC reactions with Esch. coli are: Indole positive methyl red positive, VP negative and Simmon’s citrate negative (IMViC ++- – ).

The isolated organism is confirmed by aggluti­nation test, first with polyvalent and then by individual specific O antisera. More than 164 E. coli serogroups are identified. H and K antigens of many of these serogroups have been identified.

Bacterial count in bacteriuria:

In urinary tract infection, sample of unspun mid­stream urine is inoculated in MacConkey’s agar and blood agar and incubated for overnight at 37°C. An estimate of the number of organism per ml of unspun urine sample is made by counting the number of colonies formed.

The loop of an inocula­tion wire is made such that a loopful amount of sample equals a volume of 0.01 ml. As each bacterial colony represents progeny of a single bacterium, the colony count in the plate when multiplied by 100 gives the bacterial count per ml sample. When bacterial count is 10 5 (100,000) or more per ml of urine in untreated cases of UTI, it is called significant bacteriuria.

When bacterial count is between 10,000 to 100,000 per ml, the culture may be repeated. Counts of 10,000 or less per ml are due to conta­mination during voiding and are insignificant. However, bacterial count in UTI may be lower than 100,000 per ml. in certain conditions, e.g. when the patient is on antibiotic therapy and in coccal infections (S. aureus, S. faecalis).

It is a non-motile, capsulated gram-negative rod and produces mucoid colony in solid media.

They are widely distributed in nature occurring both as commensals in human and animal mouth, upper respiratory tract and intestine, as well as saprophytes in soil, water and vegetation.

Biochemically and antigenically, Klebsiella is classified as:

1. K. pneumoniae — also called K. aero genes.

(a) K. pneumoniae:

1. Urinary tract infection, particularly those that are hospital acquired.

2. Respiratory tract infection: Occasionally it causes pneumonia.

4. Meningitis (especially in neonates).

5. Rarely abscesses, endocarditis, peritonitis and other lesions.

It causes rhinoscleroma, a chronic granulomatous growth of nose and pharynx.

It causes ozena in nasal mucosa, a disease characterised by foul-smelling nasal dis­charge with progressive atrophy of mucosal mem­branes.

Urine, sputum, pus and infected tissue depending upon site of lesion.

Gram-negative, non-motile, capsulated rods.

Large and usually mucoid colonies (due to production of extracellular slime) on MacConkey agar and blood agar. Majority of the stains produce pink colonies and MacConkey’s medium due to lactose fermentation.

Lactose fermenter, indole negative and citrate positive (see Escherichia coli). IMViC reactions are IMViC – – + + . Majority of Klebsiella strains are urease- producers but much slower and less intense in this regard than the Proteus strains.

More than 80 capsular types have been identified. Identification by Quelling reaction is recommended.

Urinary tract infection:

3. Proteus spp, especially P. mirabilis.

5. Occasionally Enterobacter, Citrobacter, Ps. aeruginosa and Serratia.

Significant bacteriuria:

When bacterial count is 10 5 (100,000) or more per ml of unspun urine sample in untreated cases of UTI, it is called significant bacteriuria.

A standard calibrated loop of 3 mm internal diameter that can hold 1/300 ml urine is used for transferring undiluted urine sample for inoculation into MacConkey agar and blood agar and then the plates are incubated overnight.

II. Non-Lactose Fermenters:

Most salmonellae are found in the gut of animals especially of pigs, cows, goats, sheep’s, rodents, hens, ducks and other poultry. They are pathogenic for their hosts and also cause disease in man. S. typhi and S. paratyphi differ from other salmonellae, in that man is the only natural host.

Salmonellae produce 3 main types of lesions but mixed forms are common.

2. Paratyphoid fever — S. paratyphi A, B and C.

(b) Food poisoning (gastroenteritis):

2. S. enteritidis phase type 4.

(c) Septicaemia with or without local suppurative lesion:

S. typhi is ingested with conta­minated food and water. The organisms then pass from small intestine into blood (transient bacte­remia) via mesenteric lymph nodes and thoracic duct. Blood stream is rapidly cleared by mono­nuclear phagocytic system in the liver, spleen and gallbladder.

From the gallbladder the organisms invade the Peyer’s patches of intestine causing inflammation and ulceration. The bacilli then pass into blood leading to bacteraemia and generalized infection. Organisms are excreted in faeces and urine in third and fourth week.

Clinically, the disease is generally milder than typhoid fever with shorter duration and incubation. S. paratyphi A and C infections are more common in tropical countries.

S. paratyphi C: It mainly causes septicaemia and important lesions caused by the organism include formation of abscess, arthritis and inflammation of gallbladder.

3. Food poisoning (enterocolitis):

Salmonella food-poisoning is caused by ingestion of contaminated food like meat, egg and milk with S. typhimurium and S. enteritidis. Symptoms occur within 10-30 hours. Food-poisoning strains can also cause septicaemia, inflammation of gallbladder and osteitis. Salmonellae causing septicaemia occasionally cause localised pyogenic lesions, such as, osteomye­litis, meningitis and deep abscesses.

Laboratory diagnosis:

Culture and isolation of salmonellae are essential to confirm a diagnosis. Identification of the isolate is based on biochemical characteristics and serology. The optimal specimen for culture varies with presen­tation.

(a) In a classic case of salmonella gastroenteritis faecal sample is best. Patients’ vomitus and suspe­cted foodstuffs are also useful.

(b) In a suspected case of enteric fever, blood culture or bone marrow aspirate is most likely to yield positive results. Later, with intestinal and renal involvement, culture of faeces and urine is indicated.

The specimens to be tested at different stages of enteric fever and the percentage of positivity are shown in Fig. 7.9 and Table 7.11. General blood picture in enteric fever may show leucopenia (leucocyte count, 2,000-2,500 cumm) with relative lymphocytosis.

Isolation of the organism:

Specimens of blood or bone marrow in enteric fever faeces, vomitus or suspected food in gastroenteritis should be collected before starting treatment. As there is transient bacteraemia, there are small number of organisms in blood. Repeated culture with larger volume (5-10 ml) of blood is necessary. Blood culture is positive in 80-90% patients in first week and up to 10 days of fever.

The chances of positive culture progressively diminishes with increase in duration of illness (Fig. 7.9). Blood culture also yields positive result during relapses. Bone- marrow material culture is as reliable as blood culture and it yields positive result in 1 to 2 days after commencement of chloramphenicol therapy.

A volume of 5 to 10 ml blood collected aseptically by venepuncture is transferred directly into a blood culture bottle containing 50 to 100 ml 0.5% glucose broth or 0.5% bile broth. Although blood culture in bile broth (selective medium for salmonellae) is most ideal for salmonellae, but in practice most laboratories use glucose broth for blood culture because all microorganisms including salmonellae grow in the medium.

Larger volume of media helps in dilution of the antibacterial substances present in the blood Liquid (sodium polyanethol sulphonate) may be added in the media which counteracts the bactericidal action of blood.

Alternatively, 5 ml venous blood, collected aseptically, is allowed to clot in a sterile screw- capped universal container. After removing serum, 15 ml bile salt streptokinase broth streptokinase, 100 units per ml) is added aseptically to each bottle.

The streptokinase digests the clot causing its lysis and thereby the bacteria are released from the clot. The separated serum is utilised for Widal test. Clot culture offers a higher rate of isolation than blood culture as the bactericidal activity of serum is obviated in the technique.

After incubation overnight at 37°C , sub-culturing is done on MacConkey agar or DCA. Sub-culturing is economically carried out by spreading a loopful of broth over a sector of solid media, one-fourth of an 8.5 cm Petri dish and incubated for 24-48 hours. Colourless colonies (NLF) appear. Cultures may be discarded as negative after 10 days.

As growth may be delayed and also to eliminate the risk of introducing contamination during repeated subcultures, Castaneda’s method of blood culture may be adopted, which provides both liquid (liver infusion broth) and solid media (3% nutrient agar slope) in one bottle. It is a diphasic medium, the broth has an agar slant on one side.

2. Stool and urine culture:

Culture of faeces and urine are always positive during 3rd and 4th week of enteric fever. Repeated cultures are required for positive result. Stool culture is mainly done for detecting the carriers.

3. Duodenal juice or bile culture:

Bile is cultured to detect chronic carriers in whom the organisms are present in the biliary tract.

In MacConkey’s agar or DCA, salmonellae grow as non-lactose fermenters which are further studied by Gram’s staining, motility preparation and biochemical reactions in different sugar media. Subculture from the colonies is made in nutrient agar to be utilised for agglutination test.

Slide agglutination test:

A loopful of isolated orga­nism (unknown culture) from the colony in agar is emulsified in a drop of saline on a microscopic slide without spreading the drop. The emulsion must be absolutely smooth and of medium opacity. One small loopful of specific antiserum is added and then mixed by tilting the slide.

In the same way, a control of bacterial suspension in normal saline is prepared on another slide and to which no specific serum is added. Clumping of bacteria in test slide occurs within a few minutes if the antigen-antibody reaction is specific. Control saline emulsion of bacteria does not show any change.

Biochemically positive strains (Box 3) are first tested with polyvalent O serum, which reacts with salmonella strains in groups A to G, provided agglutination is not blocked by Vi antigen, which can be checked by testing all negative strains using S. typhi Vi serum. Positive results with polyvalent O serum indicates a Salmonella strain.

In the next step, the strain is tested with sera prepared against O antigens of the individual salmonella groups. The following are the most useful sera which react with factor 2, Group A factors 4 and 5, group B with 6 and 7, group C1 with 8, group C2 with 9, group D and with 3, 10, 15 and 19, group E.

When the strain is positive with individual salmo­nella O serum, and biochemically it is typically S. typhi, the strain is tested against S. typhi O serum, factor 9. Prompt agglutination indicates that the microorganism belongs to Salmonella group D. Its identity is established as S. typhi by agglutination with salmonella H specific serum which reacts with flagellar antigen d.

In a non-typhoid salmonella, the strain is tested for agglutination with O and H sera for groups A, B and C. When unusual serotypes are encountered, the same should be referred to the National Salmonella Reference Centre (Central Research Institute, Kasauli, for human strain, and Indian Veterinary Research Institute, Izatnagar, for salmo­nella of animal origin).

Subtyping methods are frequently used for the common serotypes (S. typhi, S. typhi- murium and S. enteritidis) which include phage typing, bio-typing, and more recently introduced genotyping methods (plasmid finger printing). These techniques are employed in CDC for subtyping within serotypes of Salmonella.

It is an agglutination test which detects presence of serum agglutinins (H and O) in patient’s serum with typhoid and paratyphoid fever. Salmonella antibody starts appearing in serum at the end of first week and rises sharply during the 3rd week of enteric fever.

It is preferable to test two specimens of sera at an interval of 7 to 10 days to demonstrate a rising antibody titre. Convalescent sera from salmonella gastroenteritis cases often agglutinate a suspension of the causal serotype which helps in retrospective diagnosis.

In Widal test, two types of tubes were originally used: (i) Dreyer’s tube (narrow tube with conical bottom) for H agglutination, and (ii) Felix tube (short round-bottomed tube) for O aggluti­nation. Nowadays 3 x 0.5 ml Kahn tubes are used for both types of agglutination.

A serial two fold dilution of patient’s serum in normal saline (1: 20, 1: 40 and so on up to 1,280 or more) is prepared in 8 small (3 x 0.5 ml) test tubes for each series 7 for serum dilutions and 8th for a non-serum control.

To the diluted serum and control saline equal volume (0.4 cc) of antigen suspensions (TH, TO, AH and BH) are added and mixed thoroughly by shaking the rack and then the mixtures are incubated at 37°C for 4 hours and read after overnight refrigeration at 4°C. Some workers recommended incubation in a water bath at 37°C overnight.

Loose and cotton-woolly clumps are formed in H agglutination and a disc-like granular deposit in O agglutination at the bottom of tube. Control tube shows a compact deposit. The Maxi­mum dilution of serum at which agglutination occurs indicate the titre of antibodies.

The routinely used antigens are H and O of S. typhi, H of S. paratyphi A and B. As paratyphoid O antigen cross reacts with typhoid O antigen due to the sharing of factor 12 by them, paratyphoid O antigens are not used.

Preparation of Widal antigen:

H suspension of bacteria is prepared by adding 0.1% formalin to a 24 hours broth culture or saline suspension of an agar culture. For preparation of O suspension of bacteria, the organisms are cultured on phenol agar (1: 800). Standard smooth strains of the organism are used S. typhi 901, O and H strains are employed for this purpose.

Interpretation of Widal test:

1. Agglutinin starts appearing in serum by the end of 1st week with sharp rise in 2nd and 3rd weeks and the titre remains steady till the 4th week after which it declines.

Demonstration of rising titre of four-fold or greater of both H and O agglutinins at an interval of 4 to 7 days is the most important diagnostic criterion.

3. In a single test, a titre of 100 of O or more and a titre of 200 of H agglutinins signifies presence of active infection, but that has to be interpreted taking into consideration the following factors:

Due to sub-clinical infection of salmonellosis in endemic area, low titre of agglu­tinins is present in the serum of normal individuals, which may cause positive reaction. This is known as local titre. Local titre is up to 80 in Kolkata and 60 in Siliguri.

In immunization with TAB vaccine, vaccinated individuals may show high titres of antibody (H antibody titre 160 or more) to each of the salmonellae.

(iii) Anamnestic reaction:

Persons who had past enteric infection or who have been vaccinated may develop transient fever like malaria, influenza etc.

(iv) Non-specific antigens (e.g. fimbrial antigen) may produce false positive result.

(v) Antibiotic treatment:

When treatment with chloramphenicol is started before the appearance of agglutinins, they are unlikely to appear subse­quently if the antibody is already present, no further rise in titre is expected.

Widal tests may be negative in many healthy carriers and some have to be detected by Vi agglutination test.

2. Other serological tests:

ELISA is sensitive method of measuring antibody against the lipopolysaccharide of Salmonellae, titre of IgM antibody corresponds fairly well with the Widal O titre. ELISA in vertical flow membrane format (Typhi- DOT) detects Vi Ag in blood/serum at an early stage of the disease.

Shigella species are exclusively parasites of human and other primates and cause bacillary dysentery in man.

Shigellae are gram-negative non- motile bacilli. Antigenically, shigellae are divided into four groups (A, B, C, D) based on specificity of O antigen. These groups are differentiated by a combination of biochemical reactions and antigenic structure. Mannitol fermentation reactions are important, group A is mannitol negative and the rest are mannitol positive.

Shigella species cause bacillary dysentery (shi­gellosis). Infection is transmitted by faecal-oral route. S. dysenteriae type 1 (S. shiga) produces exotoxins that causes most severe form of disease. S. flexneri and S. boydii cause less severe dysentery and are prevalent in tropical countries including India. S. sonnei is the cause of most dysentery in Britain.

The organisms are taken up by the epithelial cells of distal parts of the colon with necrosis of surface epithelial cells leading to an acute inflammation in lamina propria and sub-mucosa. Necrotic epithelia sloughs forming superficial ulcers which leads to bleeding mucosa.

Laboratory diagnosis:

To confirm diagnosis, shigella must be isolated in pure culture from an adequate sample. Specimens include fresh stool, mucous flakes, and rectal swabs.

A. Microscopical examination of stool:

Cover slip preparation in saline and iodine shows large number of pus cells (neutrophils) with degenerated nuclei, RBC, and macrophages. The presence of protozoa, cysts or helminthic ova is excluded. The normal bacterial flora is considerably diminished. Fluorescent antibody technique is of some help in rapid diagnosis of a case but it is not usually practiced.

B. Bacteriological examination:

MacConkey’s agar, DCA, S-S agar, Selenite F broth.

A loopful of material is inoculated on selective media like MacConkey’s agar or SS agar media.

Selenite-F broth (0.4%) is used as enrichment and transport medium which permits rapid growth of enteric pathogens while temporarily (for 9-12 hours) inhibiting the growth of E. coli. Organisms from selenite-F broth are sub-cultured in MacConkey’s agar after 24 hours incubation at 37°C.

Colourless colonies appear on MacConkey’s agar medium after 12 to 18 hours incubation which is further tested by smear examination, motility preparation and biochemical reactions. Shigellae are Gram-negative non-motile bacilli.

II. Biochemical reactions:

Urease, citrate, H2S and KCN negative indole and M R positive Gram-negative non-sporing bacillus is suggestive of a shigella strain (Fig. 7.10). S. sonnei is a late lactose fermenter.

III. Slide agglutination test:

It is done by using polyvalent antisera of three groups (A, B and C) of shigella and antiserum of group D (S. sonnei), one by one against the isolate. Monovalent antisera are used for the group for which agglutination has occurred with polyvalent antisera. Then type specific antisera for strains belonging to Group A, B or C is used for agglutination test.

Occasionally, agglutination may not occur due to masking of O antigen by K antigen, which can be removed by boiling the bacterial suspension at 100°C for 60 minutes.

It is done for group D strains.

V. Sereny test may be done to confirm the invasiveness of the isolated strain of shigella, although, it is seldom practiced.


References

Palsson, B. Ø. Systems Biology: Constraint-Based Reconstruction and Analysis (Cambridge University Press, Cambridge, 2015).

O’Brien, E. J., Monk, J. M. & Palsson, B. O. Using genome-scale models to predict biological capabilities. Cell 161, 971–987 (2015).

Becker, S. A. et al. Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox. Nat. Protoc. 2, 727–738 (2007).

Schellenberger, J. et al. Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0. Nat. Protoc. 6, 1290–1307 (2011).

Lewis, N. E., Nagarajan, H. & Palsson, B. O. Constraining the metabolic genotype–phenotype relationship using a phylogeny of in silico methods. Nat. Rev. Microbiol. 10, 291–305 (2012).

Thiele, I. & Palsson, B. Ø. A protocol for generating a high-quality genome-scale metabolic reconstruction. Nat. Protoc. 5, 93–121 (2010).

Kitano, H., Ghosh, S. & Matsuoka, Y. Social engineering for virtual ‘big science’ in systems biology. Nat. Chem. Biol. 7, 323–326 (2011).

Bordbar, A., Monk, J. M., King, Z. A. & Palsson, B. O. Constraint-based models predict metabolic and associated cellular functions. Nat. Rev. Genet. 15, 107–120 (2014).

Maia, P., Rocha, M. & Rocha, I. In silico constraint-based strain optimization methods: the quest for optimal cell factories. Microbiol. Mol. Biol. Rev. 80, 45–67 (2016).

Hefzi, H. et al. A consensus genome-scale reconstruction of Chinese hamster ovary cell metabolism. Cell Syst. 3, 434–443.e8 (2016).

Yusufi, F. N. K. et al. Mammalian systems biotechnology reveals global cellular adaptations in a recombinant CHO cell line. Cell Syst. 4, 530–542.e6 (2017).

Zhuang, K. et al. Genome-scale dynamic modeling of the competition between Rhodoferax and Geobacter in anoxic subsurface environments. ISME J 5, 305–316 (2011).

Jamshidi, N. & Palsson, B. Ø. Systems biology of the human red blood cell. Blood Cells Mol. Dis. 36, 239–247 (2006).

Yizhak, K., Gabay, O., Cohen, H. & Ruppin, E. Model-based identification of drug targets that revert disrupted metabolism and its application to ageing. Nat. Commun. 4, 2632 (2013).

Shlomi, T., Cabili, M. N. & Ruppin, E. Predicting metabolic biomarkers of human inborn errors of metabolism. Mol. Syst. Biol. 5, 263 (2009).

Sahoo, S., Franzson, L., Jonsson, J. J. & Thiele, I. A compendium of inborn errors of metabolism mapped onto the human metabolic network. Mol. Biosyst. 8, 2545–2558 (2012).

Thiele, I. et al. A community-driven global reconstruction of human metabolism. Nat. Biotechnol. 31, 419–425 (2013).

Pagliarini, R. & di Bernardo, D. A genome-scale modeling approach to study inborn errors of liver metabolism: toward an in silico patient. J. Comput. Biol. 20, 383–397 (2013).

Shaked, I., Oberhardt, M. A., Atias, N., Sharan, R. & Ruppin, E. Metabolic network prediction of drug side effects. Cell Syst. 2, 209–213 (2016).

Chang, R. L., Xie, L., Xie, L., Bourne, P. E. & Palsson, B. Drug off-target effects predicted using structural analysis in the context of a metabolic network model. PLoS Comput. Biol. 6, e1000938 (2010).

Kell, D. B. Systems biology, metabolic modelling and metabolomics in drug discovery and development. Drug Discov. Today 11, 1085–1092 (2006).

Duarte, N. C. et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl. Acad. Sci. USA 104, 1777–1782 (2007).

Swainston, N. et al. Recon 2.2: from reconstruction to model of human metabolism. Metabolomics 12, 109 (2016).

Pornputtapong, N., Nookaew, I. & Nielsen, J. Human metabolic atlas: an online resource for human metabolism. Database 2015, bav068 (2015).

Zielinski, D. C. et al. Systems biology analysis of drivers underlying hallmarks of cancer cell metabolism. Sci. Rep. 7, 41241 (2017).

Mardinoglu, A. et al. Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease. Nat. Commun. 5, 3083 (2014).

Karlstädt, A. et al. CardioNet: a human metabolic network suited for the study of cardiomyocyte metabolism. BMC Syst. Biol. 6, 114 (2012).

Gille, C. et al. HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology. Mol. Syst. Biol. 6, 411 (2010).

Martins Conde Pdo, R., Sauter, T. & Pfau, T. Constraint based modeling going multicellular. Front. Mol. Biosci. 3, 3 (2016).

Bordbar, A. et al. A multi-tissue type genome-scale metabolic network for analysis of whole-body systems physiology. BMC Syst. Biol. 5, 180 (2011).

Yizhak, K. et al. Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer. Elife 3, e03641 (2014).

Mardinoglu, A. et al. Integration of clinical data with a genome-scale metabolic model of the human adipocyte. Mol. Syst. Biol. 9, 649 (2013).

Bordbar, A. et al. Personalized whole-cell kinetic models of metabolism for discovery in genomics and pharmacodynamics. Cell Syst. 1, 283–292 (2015).

Shoaie, S. et al. Quantifying diet-induced metabolic changes of the human gut microbiome. Cell Metab. 22, 320–331 (2015).

Nogiec, C. D. & Kasif, S. To supplement or not to supplement: a metabolic network framework for human nutritional supplements. PLoS ONE 8, e68751 (2013).

Heinken, A., Sahoo, S., Fleming, R. M. T. & Thiele, I. Systems-level characterization of a host-microbe metabolic symbiosis in the mammalian gut. Gut Microbes 4, 28–40 (2013).

Heinken, A. et al. Functional metabolic map of Faecalibacterium prausnitzii, a beneficial human gut microbe. J. Bacteriol. 196, 3289–3302 (2014).

Magnúsdóttir, S. et al. Generation of genome-scale metabolic reconstructions for 773 members of the human gut microbiota. Nat. Biotechnol. 35, 81–89 (2017).

Lakshmanan, M., Koh, G., Chung, B. K. S. & Lee, D.-Y. Software applications for flux balance analysis. Brief Bioinform. 15, 108–122 (2014).

Ebrahim, A., Lerman, J. A., Palsson, B. O. & Hyduke, D. R. COBRApy: constraints-based reconstruction and analysis for Python. BMC Syst. Biol. 7, 74 (2013).

Arkin, A. P. et al. The United States Department of Energy Systems Biology Knowledgebase. Nat. Biotechnol. 36, 566–569 (2018).

Heirendt, L., Thiele, I. & Fleming, R. M. T. DistributedFBA.jl: high-level, high-performance flux balance analysis in Julia. Bioinformatics 33, 1421–1423 (2017).

Latendresse, M., Krummenacker, M., Trupp, M. & Karp, P. D. Construction and completion of flux balance models from pathway databases. Bioinformatics 28, 388–396 (2012).

Karp, P. D. et al. Pathway Tools version 19.0 update: software for pathway/genome informatics and systems biology. Brief Bioinform. 17, 877–890 (2016).

Sandve, G. K., Nekrutenko, A., Taylor, J. & Hovig, E. Ten simple rules for reproducible computational research. PLoS Comput. Biol. 9, e1003285 (2013).

Ince, D. C., Hatton, L. & Graham-Cumming, J. The case for open computer programs. Nature 482, 485–488 (2012).

Gevorgyan, A., Bushell, M. E., Avignone-Rossa, C. & Kierzek, A. M. SurreyFBA: a command line tool and graphics user interface for constraint-based modeling of genome-scale metabolic reaction networks. Bioinformatics 27, 433–434 (2011).

Thorleifsson, S. G. & Thiele, I. rBioNet: a COBRA toolbox extension for reconstructing high-quality biochemical networks. Bioinformatics 27, 2009–2010 (2011).

Sauls, J. T. & Buescher, J. M. Assimilating genome-scale metabolic reconstructions with modelBorgifier. Bioinformatics 30, 1036–1038 (2014).

Noronha, A. et al. ReconMap: an interactive visualization of human metabolism. Bioinformatics 33, 605–607 (2017).

Gawron, P. et al. MINERVA—a platform for visualization and curation of molecular interaction networks. npj Syst. Biol. Appl. 2, 16020 (2016).

Olivier, B. G., Rohwer, J. M. & Hofmeyr, J.-H. S. Modelling cellular systems with PySCeS. Bioinformatics 21, 560–561 (2005).

Gelius-Dietrich, G., Desouki, A. A., Fritzemeier, C. J. & Lercher, M. J. Sybil—efficient constraint-based modelling in R. BMC Syst. Biol. 7, 125 (2013).

Ma, D. et al. Reliable and efficient solution of genome-scale models of metabolism and macromolecular expression. Sci. Rep. 7, 40863 (2017).

Klamt, S., Saez-Rodriguez, J. & Gilles, E. D. Structural and functional analysis of cellular networks with CellNetAnalyzer. BMC Syst. Biol. 1, 2 (2007).

Klamt, S. & von Kamp, A. An application programming interface for CellNetAnalyzer. Biosystems 105, 162–168 (2011).

Apaolaza, I. et al. An in-silico approach to predict and exploit synthetic lethality in cancer metabolism. Nat. Commun. 8, 459 (2017).

Maranas, C. D. & Zomorrodi, A. R. Optimization Methods in Metabolic Networks (Wiley, New York, 2016).

Chowdhury, A., Zomorrodi, A. R. & Maranas, C. D. Bilevel optimization techniques in computational strain design. Comp. Chem. Eng. 72, 363–372 (2015).

Thiele, I. et al. Multiscale modeling of metabolism and macromolecular synthesis in E. coli and its application to the evolution of codon usage. PLoS ONE 7, e45635 (2012).

Feist, A. M. et al. A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information. Mol. Syst. Biol. 3, 121 (2007).

Thiele, I., Jamshidi, N., Fleming, R. M. T. & Palsson, B. Ø. Genome-scale reconstruction of Escherichia coli’s transcriptional and translational machinery: a knowledge base, its mathematical formulation, and its functional characterization. PLoS Comput. Biol. 5, e1000312 (2009).

Yang, L. et al. Systems biology definition of the core proteome of metabolism and expression is consistent with high-throughput data. Proc. Natl. Acad. Sci. USA 112, 10810–10815 (2015).

Bornstein, B. J., Keating, S. M., Jouraku, A. & Hucka, M. LibSBML: an API library for SBML. Bioinformatics 24, 880–881 (2008).

Aurich, M. K., Fleming, R. M. T. & Thiele, I. MetaboTools: a comprehensive toolbox for analysis of genome-scale metabolic models. Front. Physiol. 7, 327 (2016).

Brunk, E. et al. Recon 3D: a resource enabling a three-dimensional view of gene variation in human metabolism. Nat. Biotechnol. 36, 272–281 (2018).

Ma, D. & Saunders, M. A. Solving multiscale linear programs using the simplex method in quadruple precision. in Numerical Analysis and Optimization, Vol. 134 (eds. Al-Baali, M., Grandinetti, L. & Purnama, A.) 223–235 (Springer International Publishing, Cham, Switzerland, 2015).

Fleming, R. M. T. & Thiele, I. Mass conserved elementary kinetics is sufficient for the existence of a non-equilibrium steady state concentration. J. Theor. Biol. 314, 173–181 (2012).

Gevorgyan, A., Poolman, M. G. & Fell, D. A. Detection of stoichiometric inconsistencies in biomolecular models. Bioinformatics 24, 2245–2251 (2008).

Orth, J. D., Thiele, I. & Palsson, B. Ø. What is flux balance analysis? Nat. Biotechnol. 28, 245–248 (2010).

Feist, A. M. & Palsson, B. O. The biomass objective function. Curr. Opin. Microbiol. 13, 344–349 (2010).

Meléndez-Hevia, E. & Isidoro, A. The game of the pentose phosphate cycle. J. Theor. Biol. 117, 251–263 (1985).

Orth, J. D. & Palsson, B. Ø. Systematizing the generation of missing metabolic knowledge. Biotechnol. Bioeng. 107, 403–412 (2010).

Yamada, T. et al. Prediction and identification of sequences coding for orphan enzymes using genomic and metagenomic neighbours. Mol. Syst. Biol. 8, 581 (2012).

Liberal, R. & Pinney, J. W. Simple topological properties predict functional misannotations in a metabolic network. Bioinformatics 29, i154–i161 (2013).

Reed, J. L. et al. Systems approach to refining genome annotation. Proc. Natl. Acad. Sci. USA 103, 17480–17484 (2006).

Orth, J. D. & Palsson, B. Gap-filling analysis of the iJO1366 Escherichia coli metabolic network reconstruction for discovery of metabolic functions. BMC Syst. Biol. 6, 30 (2012).

Chang, R. L. et al. Metabolic network reconstruction of Chlamydomonas offers insight into light-driven algal metabolism. Mol. Syst. Biol. 7, 518 (2011).

Rolfsson, O., Palsson, B. Ø. & Thiele, I. The human metabolic reconstruction Recon 1 directs hypotheses of novel human metabolic functions. BMC Syst. Biol. 5, 155 (2011).

Rolfsson, Ó., Paglia, G., Magnusdóttir, M., Palsson, B. Ø. & Thiele, I. Inferring the metabolism of human orphan metabolites from their metabolic network context affirms human gluconokinase activity. Biochem. J. 449, 427–435 (2013).

Satish Kumar, V., Dasika, M. S. & Maranas, C. D. Optimization based automated curation of metabolic reconstructions. BMC Bioinformatics 8, 212 (2007).

Thiele, I., Vlassis, N. & Fleming, R. M. T. fastGapFill: efficient gap filling in metabolic networks. Bioinformatics 30, 2529–2531 (2014).

Willemsen, A. M. et al. MetDFBA: incorporating time-resolved metabolomics measurements into dynamic flux balance analysis. Mol. Biosyst. 11, 137–145 (2014).

Kleessen, S., Irgang, S., Klie, S., Giavalisco, P. & Nikoloski, Z. Integration of transcriptomics and metabolomics data specifies the metabolic response of Chlamydomonas to rapamycin treatment. Plant J. 81, 822–835 (2015).

Bordbar, A. et al. Elucidating dynamic metabolic physiology through network integration of quantitative time-course metabolomics. Sci. Rep. 7, 46249 (2017).

Blazier, A. S. & Papin, J. A. Integration of expression data in genome-scale metabolic network reconstructions. Front. Physiol. 3, 299 (2012).

Opdam, S. et al. A systematic evaluation of methods for tailoring genome-scale metabolic models. Cell Syst. 4, 318–329.e6 (2017).

Estévez, S. R. & Nikoloski, Z. Generalized framework for context-specific metabolic model extraction methods. Front. Plant Sci. 5, 491 (2014).

Vlassis, N., Pacheco, M. P. & Sauter, T. Fast reconstruction of compact context-specific metabolic network models. PLoS Comput. Biol. 10, e1003424 (2014).

Becker, S. A. & Palsson, B. O. Context-specific metabolic networks are consistent with experiments. PLoS Comput. Biol. 4, e1000082 (2008).

Zur, H., Ruppin, E. & Shlomi, T. iMAT: an integrative metabolic analysis tool. Bioinformatics 26, 3140–3142 (2010).

Agren, R. et al. Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT. PLoS Comp. Biol. 8, e1002518 (2012).

Jerby, L., Shlomi, T. & Ruppin, E. Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism. Mol. Syst. Biol. 6, 401 (2010).

Wang, Y., Eddy, J. A. & Price, N. D. Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE. BMC Syst. Biol. 6, 153 (2012).

Kuhar, M. J. On the use of protein turnover and half-lives. Neuropsychopharmacology 34, 1172–1173 (2008).

Lajtha, A. & Sylvester, V. Handbook of Neurochemistry and Molecular Neurobiology (Springer, Boston, 2008).

Schuster, S. & Hilgetag, C. On elementary flux modes in biochemical reaction systems at steady state. J. Biol. Syst. 02, 165–182 (1994).

Schilling, C. H., Letscher, D. & Palsson, B. Ø. Theory for the systemic definition of metabolic pathways and their use in interpreting metabolic function from a pathway-oriented perspective. J. Theor. Biol. 203, 229–248 (2000).

Klamt, S. et al. From elementary flux modes to elementary flux vectors: metabolic pathway analysis with arbitrary linear flux constraints. PLoS Comput. Biol. 13, e1005409 (2017).

Bordbar, A. et al. Minimal metabolic pathway structure is consistent with associated biomolecular interactions. Mol. Syst. Biol. 10, 737 (2014).

Gudmundsson, S. & Thiele, I. Computationally efficient flux variability analysis. BMC Bioinformatics 11, 489 (2010).

Haraldsdóttir, H. S., Cousins, B., Thiele, I., Fleming, R. M. T. & Vempala, S. CHRR: coordinate hit-and-run with rounding for uniform sampling of constraint-based models. Bioinformatics 33, 1741–1743 (2017).

Cousins, B. & Vempala, S. Gaussian cooling and algorithms for volume and Gaussian volume. SIAM J. Comput. 47, 1237–1273 (2018).

Cousins, B. & Vempala, S. A practical volume algorithm. Math. Prog. Comp. 8, 1–28 (2015).

Burgard, A. P., Pharkya, P. & Maranas, C. D. Optknock: a bilevel programming framework for identifying gene knockout strategies for microbial strain optimization. Biotechnol. Bioeng. 84, 647–657 (2003).

Patil, K. R., Rocha, I., Förster, J. & Nielsen, J. Evolutionary programming as a platform for in silico metabolic engineering. BMC Bioinformatics 6, 308 (2005).

Lun, D. S. et al. Large-scale identification of genetic design strategies using local search. Mol. Syst. Biol. 5, 296 (2009).

Ranganathan, S., Suthers, P. F. & Maranas, C. D. OptForce: an optimization procedure for identifying all genetic manipulations leading to targeted overproductions. PLoS Comput. Biol. 6, e1000744 (2010).

Antoniewicz, M. R. et al. Metabolic flux analysis in a nonstationary system: fed-batch fermentation of a high yielding strain of E. coli producing 1,3-propanediol. Metab. Eng. 9, 277–292 (2007).

Haraldsdóttir, H. S., Thiele, I. & Fleming, R. M. T. Comparative evaluation of open source software for mapping between metabolite identifiers in metabolic network reconstructions: application to Recon 2. J. Cheminform. 6, 2 (2014).

Preciat Gonzalez, G. A. et al. Comparative evaluation of atom mapping algorithms for balanced metabolic reactions: application to Recon 3D. J. Cheminform. 9, 39 (2017).

Kim, S. et al. PubChem substance and compound databases. Nucleic Acids Res. 44, D1202–D1213 (2016).

Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27–30 (2000).

Hastings, J. et al. The ChEBI reference database and ontology for biologically relevant chemistry: enhancements for 2013. Nucleic Acids Res. 41, D456–D463 (2013).

Sud, M. et al. LMSD: LIPID MAPS structure database. Nucleic Acids Res. 35, D527–D532 (2007).

Forster, M., Pick, A., Raitner, M., Schreiber, F. & Brandenburg, F. J. The system architecture of the BioPath system. In Silico Biol. 2, 415–426 (2002).

Williams, A. J., Tkachenko, V., Golotvin, S., Kidd, R. & McCann, G. ChemSpider—building a foundation for the semantic web by hosting a crowd sourced databasing platform for chemistry. J. Cheminform. 2, O16 (2010).

Wishart, D. S. et al. HMDB: the Human Metabolome Database. Nucleic Acids Res. 35, D521–D526 (2007).

Rahman, S. A. et al. Reaction Decoder Tool (RDT): extracting features from chemical reactions. Bioinformatics 32, 2065–2066 (2016).

Kumar, A. & Maranas, C. D. CLCA: maximum common molecular substructure queries within the MetRxn Database. J. Chem. Inf. Model. 54, 3417–3438 (2014).

Shimizu, Y., Hattori, M., Goto, S. & Kanehisa, M. Generalized reaction patterns for prediction of unknown enzymatic reactions. Genome Inform. 20, 149–158 (2008).

Haraldsdóttir, H. S. & Fleming, R. M. T. Identification of conserved moieties in metabolic networks by graph theoretical analysis of atom transition networks. PLoS Comput. Biol. 12, e1004999 (2016).

Klamt, S., Haus, U.-U. & Theis, F. Hypergraphs and cellular networks. PLoS Comput. Biol. 5, e1000385 (2009).

Fleming, R. M. T. & Thiele, I. von Bertalanffy 1.0: a COBRA toolbox extension to thermodynamically constrain metabolic models. Bioinformatics 27, 142–143 (2011).

Fleming, R. M. T., Thiele, I. & Nasheuer, H. P. Quantitative assignment of reaction directionality in constraint-based models of metabolism: application to Escherichia coli. Biophys. Chem. 145, 47–56 (2009).

Haraldsdóttir, H. S., Thiele, I. & Fleming, R. M. T. Quantitative assignment of reaction directionality in a multicompartmental human metabolic reconstruction. Biophys. J. 102, 1703–1711 (2012).

Noor, E., Haraldsdóttir, H. S., Milo, R. & Fleming, R. M. T. Consistent estimation of Gibbs energy using component contributions. PLoS Comput. Biol. 9, e1003098 (2013).

Fleming, R. M. T., Maes, C. M., Saunders, M. A., Ye, Y. & Palsson, B. Ø. A variational principle for computing nonequilibrium fluxes and potentials in genome-scale biochemical networks. J. Theor. Biol. 292, 71–77 (2012).

Beard, D. A., Liang, S.-D. & Qian, H. Energy balance for analysis of complex metabolic networks. Biophys. J. 83, 79–86 (2002).

Qian, H. & Beard, D. A. Thermodynamics of stoichiometric biochemical networks in living systems far from equilibrium. Biophys. Chem. 114, 213–220 (2005).

Fleming, R. M. T., Thiele, I., Provan, G. & Nasheuer, H. P. Integrated stoichiometric, thermo- dynamic and kinetic modelling of steady state metabolism. J. Theor. Biol. 264, 683–692 (2010).

Schellenberger, J., Lewis, N. E. & Palsson, B. Ø. Elimination of thermodynamically infeasible loops in steady-state metabolic models. Biophys. J. 100, 544–553 (2011).

Soh, K. C. & Hatzimanikatis, V. Network thermodynamics in the post-genomic era. Curr. Opin. Microbiol. 13, 350–357 (2010).

Fleming, R. M. T., Vlassis, N., Thiele, I. & Saunders, M. A. Conditions for duality between fluxes and concentrations in biochemical networks. J. Theor. Biol. 409, 1–10 (2016).

​Aragón Artacho, F.J., Fleming, R. M. T. & Vuong, P. T. Accelerating the DC algorithm for smooth functions. Math. Program. 169, 95–118 (2018).

Artacho, F. J. A. & Fleming, R. M. T. Globally convergent algorithms for finding zeros of duplomonotone mappings. Optim. Lett. 9, 1–16 (2014).

Ahookhosh, M., Aragón, F. J., Fleming, R. M. T. & Vuong, P. T. Local convergence of Levenberg-Marquardt methods under Hölder metric subregularity. Preprint at https://arxiv.org/abs/1703.07461 (2017).

Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).

King, Z. A. et al. Escher: a web application for building, sharing, and embedding data-rich visualizations of biological pathways. PLoS Comput. Biol. 11, e1004321 (2015).

Kuperstein, I. et al. NaviCell: a web-based environment for navigation, curation and maintenance of large molecular interaction maps. BMC Syst. Biol. 7, 100 (2013).

Kostromins, A. & Stalidzans, E. Paint4net: COBRA Toolbox extension for visualization of stoichiometric models of metabolism. Biosystems 109, 233–239 (2012).

Aurich, M. K. et al. Prediction of intracellular metabolic states from extracellular metabolomic data. Metabolomics 11, 603–619 (2014).

Guebila, M. B. & Thiele, I. Model-based dietary optimization for late-stage, levodopa-treated, Parkinson’s disease patients. npj Syst. Biol. Appl. 2, 16013 (2016).

Sun, Y., Fleming, R. M. T., Thiele, I. & Saunders, M. A. Robust flux balance analysis of multiscale biochemical reaction networks. BMC Bioinformatics 14, 240 (2013).

Lewis, N. E. et al. Omic data from evolved E. coli are consistent with computed optimal growth from genome-scale models. Mol. Syst. Biol. 6, 390 (2010).

Thiele, I., Fleming, R. M. T., Bordbar, A., Schellenberger, J. & Palsson, B. Ø. Functional characterization of alternate optimal solutions of Escherichia coli’s transcriptional and translational machinery. Biophys. J. 98, 2072–2081 (2010).

Ballerstein, K., von Kamp, A., Klamt, S. & Haus, U.-U. Minimal cut sets in a metabolic network are elementary modes in a dual network. Bioinformatics 28, 381–387 (2012).

von Kamp, A. & Klamt, S. Enumeration of smallest intervention strategies in genome-scale metabolic networks. PLoS Comput. Biol. 10, e1003378 (2014).

Fujita, K. A. et al. Integrating pathways of Parkinson’s disease in a molecular interaction map. Mol. Neurobiol. 49, 88–102 (2014).

Agren, R. et al. The RAVEN Toolbox and its use for generating a genome-scale metabolic model for Penicillium chrysogenum. PLoS Comput. Biol. 9, e1002980 (2013).

Grafahrend-Belau, E., Klukas, C., Junker, B. H. & Schreiber, F. FBA-SimVis: interactive visualization of constraint-based metabolic models. Bioinformatics 25, 2755–2757 (2009).

Rocha, I. et al. OptFlux: an open-source software platform for in silico metabolic engineering. BMC Syst. Biol. 4, 45 (2010).

Poolman, M. G. ScrumPy: metabolic modelling with Python. Syst. Biol. 153, 375–378 (2006).

Hoppe, A., Hoffmann, S., Gerasch, A., Gille, C. & Holzhütter, H.-G. FASIMU: flexible software for flux-balance computation series in large metabolic networks. BMC Bioinformatics 12, 28 (2011).

Boele, J., Olivier, B. G. & Teusink, B. FAME, the flux analysis and modeling environment. BMC Syst. Biol. 6, 8 (2012).


Completed Test

Since some of the positive results from the confirmatory test may be false, it is desirable to do completed tests. For this inoculum from each positive tube of the confirmatory test is streaked on a plate of EMB or Endo agar.

In this process, a loopful of a sample from each positive BGLB tube is streaked onto selective medium like Eosin Methylene Blue agar or Endo’s medium. One plate each is incubated at 37°C and another at 44.5± 0.2°C for 24 hours.


Watch the video: Biochemical Tests-Part 1 (June 2022).


Comments:

  1. Abraham

    Incomparable topic

  2. JoJoll

    Wonderful, it is a precious answer

  3. Arasho

    You are not right. Write in PM.

  4. Demogorgon

    Today I read a lot on this issue.



Write a message